Loading…

Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review

Saved in:

Bibliographic Details
Published in:	Frontiers in oncology 2021, Vol.11, p.726134-726134
Main Authors:	Feng, Gang, Li, Qing, Zhu, Haibo, Jiang, Yanyu, Yuan, Jijun, Fu, Yingxin, Deng, Qi
Format:	Report
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!